创建一个治疗自身免疫性胃炎的框架 - 替代丢失的酸的案例
Lori Taylor1, Andrew McCaddon2, Bruce H R Wolffenbuttel3
1Faculty of Integrative and Functional Nutrition, Saybrook University, Pasadena, CA 91103, USA.
Nutrients
|March 13, 2024
概括
自身免疫性胃炎 (AIG) 导致胃酸低,增加癌症风险. 补充贝他因化可以恢复酸度,可能降低与AIG相关的风险.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 自身免疫性胃炎 (AIG) 涉及胃壁膜细胞的破坏,导致低水和亚水.
- 胃酸在AIG中的损失增加了超胃血和N-nitroso化合物的风险,从而增加了胃癌的风险.
- 目前的AIG管理层经常忽视酸替代,可能不适当地使用酸抑制.
研究的目的:
- 审查胃酸在胃肠道和免疫健康中的作用.
- 为了记录AIG患者中低水的后果.
- 建议安全的方法,以恢复胃酸在AIG.
主要方法:
- 现有文献的叙述性审查.
- 胃酸生理功能的分析.
- 对AIG相关的低水化合物的潜在治疗干预措施的评估.
主要成果:
- 胃酸对于消化和免疫功能至关重要.
- 在AIG中含有的高化物有助于显著的健康风险,包括癌症.
- 贝他因化和维生素C是管理AIG后续的潜在药物.
结论:
- 在AIG中恢复胃酸度可能会减轻超胃血和N-nitroso化合物形成.
- 与维生素C一起补充酸,可以为AIG提供一种新的治疗策略.
- 需要进一步的研究来验证AIG的再酸化的安全性和有效性.
相关概念视频
Gastritis-I: Introduction and Types
399
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
399
Gastritis-II: Pathophysiology
324
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
324
Gastritis III: Clinical Manifestations and Management
240
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
240
Peptic Ulcer Disease IV: Management
91
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
484
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
484
Gastroesophageal Reflux Disease II: Clinical Features and Management
80
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
80


